Related Experiment Video

Updated: Jun 22, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Increases in serum concentration of human heart-type fatty acid-binding protein following elective coronary

Eftihia Sbarouni1, Panagiota Georgiadou, Ioannis Sklavainas

  • 1Second Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece. esbarouni@yahoo.gr

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|June 26, 2009
PubMed

Insights

Serum levels of heart-type fatty acid-binding protein (H-FABP) significantly increase 1 hour after elective coronary angioplasty. This finding suggests H-FABP may be a marker of myocardial ischemia during the procedure.

Area of Science:

  • Cardiology
  • Biomarkers
  • Ischemic Heart Disease

Background:

  • Heart-type fatty acid-binding protein (H-FABP) is a recognized marker of myocardial necrosis.
  • The impact of myocardial ischemia on H-FABP levels remains unclear.
  • Investigating H-FABP changes following coronary angioplasty is crucial.

Purpose of the Study:

  • To determine if serum H-FABP levels increase after non-urgent coronary angioplasty.
  • To assess the temporal changes in H-FABP following the procedure.

Main Methods:

  • A study involving 31 patients undergoing coronary angioplasty.
  • Peripheral venous blood samples were collected immediately before, 1 hour after balloon inflation, and 24 hours after the procedure.
  • Serum H-FABP levels were quantified using assays.

Main Results:

  • Serum H-FABP levels showed a significant increase at 1 hour post-angioplasty compared to baseline (p = 0.024).
  • No significant differences were observed between H-FABP levels at 1 hour and 24 hours post-procedure (p = 0.87).
  • No significant difference was found between 24-hour post-angioplasty levels and baseline levels (p = 0.112).

Conclusions:

  • H-FABP levels significantly rise 1 hour after elective coronary angioplasty compared to baseline.
  • The prognostic significance of this H-FABP increase, similar to troponins, requires further investigation.
  • This study highlights H-FABP as a potential indicator of myocardial ischemia during angioplasty.
Abstract

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...